» Articles » PMID: 31488891

Correction To: The SRCIN1/p140Cap Adaptor Protein Negatively Regulates the Aggressiveness of Neuroblastoma

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Citing Articles

p140Cap modulates the mevalonate pathway decreasing cell migration and enhancing drug sensitivity in breast cancer cells.

Centonze G, Natalini D, Grasso S, Morellato A, Salemme V, Piccolantonio A Cell Death Dis. 2023; 14(12):849.

PMID: 38123597 PMC: 10733353. DOI: 10.1038/s41419-023-06357-z.


The p140Cap adaptor protein as a molecular hub to block cancer aggressiveness.

Salemme V, Angelini C, Chapelle J, Centonze G, Natalini D, Morellato A Cell Mol Life Sci. 2020; 78(4):1355-1367.

PMID: 33079227 PMC: 7904710. DOI: 10.1007/s00018-020-03666-w.


Hypoxia Predicts Poor Prognosis in Neuroblastoma Patients and Associates with Biological Mechanisms Involved in Telomerase Activation and Tumor Microenvironment Reprogramming.

Cangelosi D, Morini M, Zanardi N, Sementa A, Muselli M, Conte M Cancers (Basel). 2020; 12(9).

PMID: 32825087 PMC: 7563184. DOI: 10.3390/cancers12092343.